L-DOPA improves visuo-motor coordination in stable Parkinson's disease patients

Parkinsonism and Related Disorders

Volumn 4, Issue 3, 1998, Pages 129-136

  Hocherman, S ^a,b   Alexandrovsky, L ^a,b   Badarny, S ^c   Honigman, S ^c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Eve Topf and USA National Parkinson Foundation   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

Levodopa; Parkinsonism; Visuo motor control; Wearing off

Indexed keywords

LEVODOPA; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EYE TRACKING; HAND MOVEMENT; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; VELOCITY; VISUOMOTOR COORDINATION;

EID: 0032423105     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(98)00034-0     Document Type: Article

References (20)

1. Linder MD, Plone MA, Francis JM, Emerich DF. Validation of a rodent model of Parkinson's disease: evidence of a therapeutic window for oral Sinemet. Brain Res. Bull. 1996;96(39):367-372.
2. Chase TN, Mouradian MM, Engber TM. Motor response complications and the function of striatal efferent systems. Neurol. 1993;43:S23-S27.
3. Chase TN, Engber TM, Mouradian MM. Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease. Neurol. 1994;94:S15-S18.
4. Bravi D, Mouradian MM, Roberts JW, Davis TL, Sohn YH, Chase TN. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms. Ann. Neurol. 1994;94:27-31.
5. Koller WC. Management of motor fluctuations in Parkinson's disease. Eur. Neurol. 1996;96(36):43-48.
6. Mizuno Y, Kondo T, Mori H. Various aspects of motor fluctuations and their management in Parkinson's disease. Neurol. 1994;94:S29-S34.
7. Sage JI, Mark MH. Basic mechanisms of motor fluctuations. Neurol. 1994;94:S10-S14.
8. Sawle GV, Playford ED, Brooks DJ, Quinn N, Frackowiak RS. Asymmetric presynaptic and post-synaptic changes in the striatal dopamine projection in dopa naive Parkinsonism. Diagnostic implications of the D2 receptor status. Brain 1993;116:853-867.
9. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, et al. Single photon emission tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 1993;90:11 965-11 969.
10. Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, et al. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35 428 reveals marked declines in mild Parkinson's disease. Annals of Neurology 1993;34:423-431.
11. Laihinen AO, Rinne JO, Nagren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, et al. PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease. Journal of Nuclear Medicine 1995;36:1263-1267.
12. Hocherman S, Giladi N. Visuo-motor control abnormalities in patients with unilateral Parkinsonism. Neurol. 1998;50:1648-1654.
13. Hocherman S, Aharon-Peretz J. Two dimensional tracing and tracking in patients with Parkinson's disease. Neurol. 1994;44:111-116.
14. Hocherman S, Giladi N, Early diagnosis of Parkinson's disease in new neurological patients by testing of visuo-manual coordination. In: Ohye C, Kimura M, McKenzie JS, editors. The basal ganglia V, advances in behavioral biology, Vol. 47, 1995, pp. 427-431.
15. Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Langstrom B. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurol 1996;46:1430-1436.
16. Huf schmidt A, Lucking CH. Abnormalities of tracking behavior in Parkinson's disease. Movement Disorders 1995;10:267-276.
17. Morris ME, Matyas TA, Iansek R, Summers JJ. Temporal stability of gait in Parkinson's disease. Phys. Ther. 1996;96:763-778.
18. Weller C, O'Neill CJ, Charlett A, Bowes SG, Purkiss A, Nicholson PW, Dobbs RJ, Dobbs SM. Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor. Br. J. Clin. Pharmacol. 1993;93:379-385.
19. Johnson MT, Mendez A, Kipnis AN, Silverstein P, Zwiebel F, Ebner TJ. Acute effects of levodopa on wrist movement in Parkinson's desease. Kinematics, volotional EMG modulation and reflex amplitude modulation. Brain 1994;117:1409-1422.
20. Johnson MT, Kipnis AN, Coltz JD, Gupta A, Silverstein P, Zwiebel F, Ebner TJ. Effects of levopoda and viscosity on the velocity and accuracy of visually guided tracking in Parkinson's disease. Brain 1996;119:801-813.